48,830
edits
(→IHC: tweak) |
|||
Line 339: | Line 339: | ||
==Endocervical adenocarcinoma in situ== | ==Endocervical adenocarcinoma in situ== | ||
:''For the cytology see [[ | :''For the cytology see [[Gynecologic cytopathology#Endocervical_adenocarcinoma_in_situ]]'' | ||
*[[AKA]] ''adenocarcinoma in situ'', abbreviated ''AIS''. | *[[AKA]] ''adenocarcinoma in situ'', abbreviated ''AIS''. | ||
===General=== | ===General=== | ||
Line 363: | Line 363: | ||
DDx: | DDx: | ||
* | *Tubal metaplasia. | ||
*[[Arias-Stella reaction]]. | *[[Arias-Stella reaction]]. | ||
*[[Endometriosis]]. | *[[Endometriosis]]. | ||
*Lower uterine segment epithelium<ref name=Ref_GP167>{{Ref GP|167}}</ref> - esp. [[proliferative phase endometrium]] - mitoses rare, NC ratio normal, stroma different. | *Lower uterine segment epithelium<ref name=Ref_GP167>{{Ref GP|167}}</ref> - esp. [[proliferative phase endometrium]] - mitoses rare, NC ratio normal, stroma different. | ||
*[[Endocervical adenocarcinoma]]. | |||
*[[metastatsis|Metastatic]] adenocarcinoma. | |||
===IHC=== | |||
*p16 +ve. | |||
*CEA +ve. | |||
*Vimentin -ve. | |||
=Cancer= | =Cancer= |
edits